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The cDNA derived from the fusion gene of the virulent AV strain of Newcastle disease virus (NDV) was
expressed in chicken embryo cells by using a retrovirus vector. The fusion protein expressed in this system was
transported to the cell surface and was efficiently cleaved into the disulfide-linked F1-F2 form found in infectious
virions. The cells expressing the fusion gene grew normally and could be passaged many times. Monolayers of
these cells would plaque, in the absence of trypsin, avirulent NDV strains (strains which encode a fusion protein
which is not cleaved in tissue culture). Fusion protein-expressing cells would not fuse if mixed with uninfected
cells or uninfected cells expressing the hemagglutinin-neuraminidase (HN) protein. However, the fusion
protein-expressing cells, if infected with avirulent strains of NDV, would fuse with uninfected cells, suggesting
that fusion requires both the fusion protein and another viral protein expressed in the same cell. Fusion was
also seen after transfection of the HN protein gene into fusion protein-expressing cells. Thus, the expressed
fusion protein gene is capable of complementing the virus infection, providing an active cleaved fusion protein
required for the spread of infection. However, the fusion protein does not mediate cell fusion unless the cell also
expresses the HN protein. Fusion protein-expressing cells would not plaque influenza virus in the absence of
trypsin, nor would influenza virus-infected fusion protein-expressing cells fuse with uninfected cells. Thus, the
influenza virus HA protein will not substitute for the NDV HN protein in cell-to-cell fusion.
Newcastle disease virus (NDV) is a prototype paramyxo-
virus, and like most enveloped RNA viruses, the virions are
composed of an envelope and a core. The NDV envelope
contains the hemagglutinin-neuraminidase (HN) glycopro-
tein, the fusion (F) glycoprotein, and a nonglycosylated
membrane protein (4). The core contains the genomic RNA
and the NP, P, and L proteins (4). Viral infection is initiated
by the interaction of the viral attachment protein (HN) with
a sialic acid-containing receptor (4). The subsequent fusion
of the viral and cellular membranes required for penetration
is mediated by the fusion protein (4).
The fusion protein not only mediates fusion between the
virus and the host cell membranes but also between an
infected cell and an adjacent cell (2). The fusion proteins of
paramyxoviruses are synthesized as a precursor, Fo, which
is activated by a proteolytic cleavage, resulting in F1 and F2
polypeptides which are held together by disulfide bonds (34,
35). While this cleavage always occurs during growth of the
virus in eggs, in tissue culture, the fusion protein of many
paramyxoviruses must be cleaved extracellularly by an
added protease such as trypsin (9, 25, 26). However, the
fusion proteins of some viruses are cleaved in all cell types
(25, 26). These readily cleaved fusion proteins have at their
cleavage sites two pairs of basic amino acid residues which
are recognized by ubiquitous host cell enzymes present in
the trans-Golgi membranes or the trans-Golgi network (20,
24, 39). Virulent strains of NDV encode readily cleaved
fusion proteins, while the avirulent strains of NDV have an
uncleaved fusion protein if grown in tissue culture (26). The
ability to be cleaved in tissue culture correlates with the
* Corresponding author.
presence of two pairs of basic amino acid residues at the
cleavage site (8, 40).
The requirements for membrane fusion mediated by the
paramyxovirus fusion proteins are controversial. Using var-
ious experimental approaches, it has been reported that the
fusion protein alone will mediate membrane fusion (3, 6, 36).
In contrast, other studies using reconstituted lipid vesicles
showed that the Sendai virus fusion protein by itself would
not mediate fusion (7, 10, 27, 32). However, Hsu et al. (10)
showed that the addition of wheat germ agglutinin to fusion
protein-containing vesicles resulted in membrane fusion,
suggesting that an attachment function was necessary for
cell fusion. They argued that the HN protein provides this
function but that other agents could substitute. However,
work by Gitman et al. (7) and Citovsky et al. (5), again using
Sendai virus glycoproteins, showed that both the HN and
the fusion proteins were necessary for fusion and that other
attachment proteins would not substitute for the HN protein.
Nussbaum et al. (28) reported that HN plays a role in fusion
separate from its attachment activity. In support of the
notion that the HN protein provides a specific, necessary
function in fusion was the description of monoclonal anti-
bodies directed against the HN protein which did not block
virus binding but did block membrane fusion (21, 30). More
recent experiments utilizing cDNA clones of paramyxovirus
glycoproteins further complicate the issue. It has been
reported that expression of the simian virus 5 fusion protein
(29) and the measles virus fusion protein (1) results in cells
which are fully competent in membrane fusion. Olmsted et
al. (31) report unpublished observations suggesting that the
respiratory syncytial virus fusion protein alone can also
mediate membrane fusion. However, Sakai and Shibuta (33)
report that expression of the parainfluenza 3 virus fusion
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protein is not sufficient for membrane fusion and that the
expression of both the HN and the fusion proteins is
necessary for membrane fusion.
To study the properties of the NDV fusion protein, we
expressed in chick cells the cDNA derived from the fusion
gene of a virulent strain of NDV, strain AV, using a
retrovirus vector. Because this vector is a replication-com-
petent retrovirus, the expression of the inserted gene occurs
in virtually 100% of the cells in culture. We report that the
fusion protein expressed in this system is efficiently cleaved
and transported to the cell surface. These cells do not fuse,
will grow normally, and can be passaged many times. These
cells will plaque avirulent NDV strains in the absence of
trypsin. Further, these cells will fuse if infected with the
avirulent virus or if transfected with the HN protein gene.
Thus, the expressed fusion protein is capable of comple-
menting the virus infection, providing an active cleaved
fusion protein required for the spread of the infection. The
expressed fusion protein will also complement the HN
protein gene to mediate cell-to-cell fusion.
MATERIALS AND METHODS
NDV and influenza virus. NDV strain Australia-Victoria or
AV (virulent) was grown and purified as previously de-
scribed (19, 24). Stocks of avirulent strains B1-Hitchner (Bi)
and W (8, 37) were the generous gifts of Ron Iorio. Stocks of
influenza virus were the generous gift of Frank Ennis.
Construction of plasmid DNAs. The full-length fusion pro-
tein gene was assembled from two overlapping cDNA clones
in pBR322 by using a restriction site in the overlapping
region (32a). The GC tails generated during the cloning
protocols were considered likely to be detrimental in the
retroviral life cycle and were therefore removed. Figure 1A
outlines the constructions used to eliminate the GC tails at
both ends of the gene. Use was made of restriction sites in
the 5' and 3' noncoding regions (BamI and MnI, respective-
ly). The complete coding region of the fusion protein was
assembled in pSP64 (18) by ligating three restriction frag-
ments (BamI-BamI, BamI-SphI, and SphI-MnI) into a BamI-
SmnaI-cut vector. Of the clones isolated, several were se-
quenced in the BamI-BamI region to determine which had
th, BamI-BamI fragment in the proper orientation (pSPFst).
The plasmid DNA was transcribed with SP6 polymerase
(18), and the resulting mRNA was translated to verify the
integrity of the coding region of the gene (32a).
A plasmid, pRCAS, containing a nonpermuted proviral
form of a replication-competent, nontransforming derivative
of the Schmidt-Ruppin A strain of Rous sarcoma virus, and
pCLA12N, an adaptor plasmid which facilitates introduction
of DNAs into the unique ClaI site of pRCAS (11-13), were
the generous gifts of Stephen Hughes. To insert the fusion
gene into the adaptor plasmid, pSPFst was cut with SacI and
Sail and the resulting fragment was ligated into a Sacl-Sail-
cut pCLA12N. To insert the fusion protein gene into the
retroviral vector, pCLA12NFst was cut with ClaI and the
isolated fragment containing the fusion gene was ligated into
a ClaI-cut pRCAS. The orientation of the insertion of the
fusion gene in the viral genome was determined by Sall
digestion. pRFst contained the fusion gene in the sense
direction, while pRantiFst contained the fusion gene in the
opposite orientation.
Construction of the HN protein gene containing pRCAS
DNA (pRHN) has been previously described (22).
Transfection. Early passage chicken embryo cells derived
from line 0 chickens (USDA Poultry Laboratories, East
Lansing, Mich.) (devoid of endogenous retroviruses) were
grown in Dulbecco modified Eagle medium supplemented
with 10% tryptone phosphate broth and 6% fetal calf serum.
These cells were transfected with 10 ,ug of plasmid DNA
either by the DEAE-dextran procedure followed by a 20%
dimethyl sulfoxide shock (15) or with lipofectin as recom-
mended by the manufacturer (GIBCO-Bethesda Research
Laboratories). Cells were incubated with lipofectin-DNA
mixtures for 5 h. Virus production was monitored with a
solid-phase enzyme-linked immunosorbent assay (ELISA)
for the p27 capsid protein of avian leukosis virus (ALV) (14).
Typical transfected cultures produced maximal virus titers
within 10 to 14 days posttransfection. All handling of virus-
producing cells was conducted under PL2 containment.
Radiolabeling and immunoprecipitation of viral proteins.
Unless otherwise noted, cells were radiolabeled for 2 h at
37°C in Dulbecco modified Eagle medium lacking methionine
but containing 100 ,uCi of [35S]methionine (Armersham) per
ml. At the end of the labeling period, cells were washed in
phosphate-buffered saline (PBS) and lysed in RSB buffer
(0.01 M Tris hydrochloride [pH 7.4], 0.01 M NaCl) contain-
ing 1% Triton X-100 and 0.5% sodium deoxycholate as
previously described (20, 23, 24). Nuclei were removed by
centrifugation.
For NDV-infected cell extracts, chicken embryo cells
were infected with NDV at a multiplicity of infection of 15,
cells were radioactively labeled as described above from 5 to
7 h postinfection, and extracts were prepared as described
above.
Monoclonal antibody anti-F (ROB11) was the generous
gift of Ron Iorio, while anti-F (Fula) was the generous gift of
Mark Peeples (23). Immunoprecipitation was performed as
previously described (23).
Cell surface assays. Cells were plated in 35-mm dishes at
low density for easy visualization of individual cells. Mono-
layers were washed with ice-cold PBS and incubated on ice
with anti-F (ROB11) (50 Rl of ascites fluid in 0.5 ml PBS) for
30 min. The monolayers were washed extensively in ice-cold
PBS, and then rabbit anti-mouse immunoglobulin G coupled
to beads (50 RI) (Bio-Rad) and resuspended in PBS contain-
ing 1 mg of bovine serum albumin per ml was added in a final
volume of 0.5 ml. Incubation was on ice for 30 min, and then
the unbound antibody was washed away with cold PBS. The
monolayers were fixed with 100% methanol for 2 min and
then stained with Giemsa stain (Sigma).
Fusion assays. Uninfected cells (5 x 105) were added to
subconfluent monolayers of infected or uninfected cells
growing on 35-mm dishes, and incubation was continued for
2 h. For fusion assays with NDV-infected cells, the cells
were infected with NDV at a multiplicity of infection of 8,
washed extensively after virus adsorption, and incubated for
5 h prior to the addition of uninfected cells. The cells were
fixed in methanol and stained with Giemsa stain.
Plaque assays. Purified NDV of the appropriate dilution
was added to monolayers of cells and incubated for 30 min at
37°C and then overlaid with 1% agar containing Dulbecco
modified Eagle medium supplemented with 6% fetal calf
serum. Plaque formation in the presence of trypsin was
accomplished as previously described (26).
Polyacrylamide gel electrophoresis. Polypeptides were re-
solved in 10% polyacrylamide slab gels prepared and elec-
trophoresed as previously described (20).
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FIG. 1. Plasmid constructions. Full-length fusion protein gene was assembled from two cDNA clones in pBR322 by using a restriction site
in the overlapping region (not shown). (A) To remove the GC tails from the 5' and 3' ends of the cDNA, we used restriction sites in the 5'
and 3' noncoding regions. The complete coding region of the fusion protein was assembled in pSP64 by ligating three restriction fragments
(BamI-BamI, BamI-SphI, and SphI-MnI) into a BamI-SmaI-cut vector. (B) To insert the fusion gene into the adaptor plasmid, pSP6Fst was
cut with Sacl and Sall and the resulting fragment was ligated into a Sacl-Sall-cut pCLA12N. (C) To insert the fusion gene into the retroviral
vector, pCLA12NFst was cut with ClaI and the fragment containing the fusion gene was isolated and ligated into a ClaI-cut pRCAS. The
orientation of the insertion of the fusion gene was determined by Sall digestion. LTR, Long terminal repeat; PPH, bacterial plasmid; B, BamI;
H, HindIll; P, Pstl; S, Sall; Sm, SmaI; Sac, Sacl; C, ClaI; M, MnI.
RESULTS
Expression of fusion protein in chicken embryo cells. The
full-length fusion protein gene derived from the virulent
Australia-Victoria (AV) strain of NDV was assembled from
two cDNA clones in pBR322 by using a restriction site in the
overlapping region. The GC tails generated in the cloning
protocols were removed as described in Materials and
Methods to generate pSP6Fst (Fig. 1A). DNAs containing
the complete coding region of the fusion protein gene were
inserted in both the sense (pRFst) and antisense (pRantiFst)
orientations into the Schmidt-Ruppin Rous sarcoma virus-
derived vector by using the adaptor plasmid pCLA12N (Fig.
1B and C). The DNAs as well as vector DNA without an
insert (pRCAS) were used to transfect early passage chicken
embryo cells, and culture medium was monitored for the
production of the ALV vector by using the ALV-specific
ELISA (14). Maximum titers were obtained 10 to 14 days
after transfection. The titers of the recombinant viruses were
comparable to that of the vector lacking foreign genes. Cells
transfected with the vectors containing inserts grew with the
same generation time as cells transfected with the vector
alone (data not shown). Cultures of cells transfected with the
vector containing the fusion gene in the sense direction
showed no signs of cell-to-cell fusion at any point after
transfection (see below).
The expression of the fusion protein in the transfected
cells was analyzed by immunoprecipitation with anti-fusion
protein antibody of cytoplasmic extracts prepared from cells
radiolabeled with [35S]methionine. Cells transfected with the
pRFst DNA synthesized a polypeptide (Fig. 2A, lanes 6 and
7) which comigrated with the fusion protein seen in NDV-
infected cell extracts (lanes 3 and 4). However, cells trans-
fected with the vector containing the antisense version of the
fusion protein gene (pRantiFst) (lanes 9 and 10) or vector
alone (pRCAS) (lanes 12 and 13) did not contain a fusion
protein-sized polypeptide. The two different monoclonal
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FIG. 2. Expression of the fusion protein. (A) Cells transfected with pRFst, pRantiFst, or pRCAS were radioactively labeled with
[35S]methionine for 2 h, and cytoplasmic extracts were prepared. Chick cells infected with NDV were similarly labeled, and cytoplasmic
extracts were prepared. Fusion protein present in the extracts was immunoprecipitated with two different anti-fusion protein monoclonal
antibodies. Lanes 3, 6, 9, and 12 were precipitated with antibody obtained from R. Iorio. Lanes 4, 7, 10, and 13 were precipitated with
anti-fusion protein from M. Peeples (23). Lanes 2, 5, 8, and 11 show precipitated material with no added antibody. Lane 1 shows total protein
in a cytoplasmic extract from NDV-infected cells, while lanes 2 to 4 show precipitates from the same NDV-infected cell lysate. Lanes 5 to
7 show precipitates from pRFst-transfected cells. Lanes 8 to 10 show precipitates from pRantiFst-transfected cells, and lanes 11 to 13 show
precipitates from pRCAS-transfected chick cells. All precipitated proteins were electrophoresed in the absence of reducing agent(f-mercaptoethanol [BME]). (B) Electrophoresis of proteins in the presence of reducing agent. Cells were pulse-labeled for 15 min and
subjected to a nonradioactive chase of 2 h. Lane 1 shows total extract prepared from NDV-infected cells to show the positions of all NDV
proteins; lane 2 shows the immunoprecipitated material from the same infected cell extract. The majority of the material electrophoreses with
the F1 protein, which migrates under the NP protein in the total cell extracts. Lanes 4 to 8 show precipitation of the fusion protein from
extracts prepared from cells transfected with pRFst for 4 days (lane 4), 5 days (lane 5), 15 days (lane 6), 18 days (lane 7), and 20 days (lane
8). Antibody from R. Iorio was used here and in all subsequent experiments. Lane 3 is precipitation of transfected cells in the absence of added
antibody.
antibodies specific to the fusion protein appeared to precip-
itate different forms of the fusion protein. The significance of
this observation is unclear and is under investigation.
In the absence of reducing agent, both the uncleaved (FO)
and the cleaved (F1-F2) fusion proteins migrate on polyacryl-
amide gels in the position of the Fo polypeptide (17, 38).
However, in the presence of reducing agent, the F1-F2
complex is disrupted and the F1 polypeptide in infected cells
comigrates with the NP protein (17, 38) (Fig. 2B, lanes 1 and
2). F2 in infected cell extracts or purified virions is difficult to
visualize on gels. To determine whether the fusion protein
expressed from the retrovirus vector is proteolytically
cleaved, the immunoprecipitates of cells subjected to a
pulse-chase were electrophoresed in the presence of reduc-
ing agent (Fig. 2B). The F1 protein was seen in both
NDV-infected (lane 2) and transfected (lanes 4 to 8) cells. In
addition, the same results were obtained from cells early
after transfection (lanes 4 and 5) as well as from cells
passaged for 15 to 20 days after transfection (lanes 6 to 8).
Thus, the fusion protein expressed from the retrovirus
vector is proteolytically cleaved, as is the protein synthe-
sized in NDV-infected cells.
Surface expression of fusion protein. To determine whether
the fusion protein expressed from the retrovirus vector was
inserted into the plasma membrane, we used monoclonal
antibody. Cells transfected with pRFst and cells transfected
with pRCAS were incubated with anti-fusion protein mono-
clonal antibody on ice. Unbound antibody was washed
away, and any binding of the antibody to cell surfaces was
visualized by rabbit anti-mouse monoclonal antibody cou-
pled to beads. Cells expressing the fusion protein gene (Fig.
3A) had numerous beads attached to their surfaces, while
cells transfected with pRCAS DNA (Fig. 3B) did not bind
the second antibody and had no beads bound to their
surfaces.
Inspection of the monolayers with the bound second
antibody enabled us to quantify the numbers of cells on the
plate which are expressing the fusion protein. Of 400 cells
counted, 98% of the cells transfected with the pRFst bound
the anti-fusion protein monoclonal antibody (Fig. 3A). This
efficiency of cells expressing the fusion gene is not surprising
since the vector is a replication-competent virus. Cells which
did not originally receive the DNA in the transfection
protocol will be infected with progeny virus which is re-
leased from the transfected cells. Thus, the fusion gene is
effectively spread to all cells in the population, resulting in
nearly 100% of the cells expressing the fusion gene.
Infection of fusion protein-expressing cells with NDV and
influenza virus. Cells expressing the fusion protein readily
plaqued NDV strain AV. Indeed, plaques of the AV strain
appeared in 18 h, whereas plaques on untransfected chick
cells required a 48-h incubation to be visualized. Therefore,
it appeared that the expressed fusion protein-facilitated virus
spread as assayed by plaque formation. To test this possi-
bility, we plaqued two avirulent NDV strains on the fusion
protein-expressing cells. Both NDV Bi and NDV W are
avirulent strains which will not plaque on chick cells unless
trypsin is included in the monolayer (8, 40). Both these
strains readily plaqued on fusion protein-expressing cells in
the absence of trypsin (Table 1). Indeed, the efficiency of
plaque formation was as high as that on chick cells in the
presence of trypsin. In addition, appearance of plaques on
chick cells in the presence of trypsin required 48 to 72 h,
while plaques on fusion protein-expressing cells in the ab-
sence of trypsin were readily seen in 18 h. Strains Bi and W
did not plaque in the absence of trypsin on cells transfected
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FIG. 3. Surface expression of the fusion protein. Cells transfected with pRFst (A) and cells transfected with pRCAS (B) were plated at
low density. Monolayers were washed with PBS and incubated with monoclonal antibody specific for the fusion protein. Incubation was on
ice for 30 min. Unbound antibody was removed, the monolayers were washed extensively with cold PBS, and anti-mouse immunoglobulin
G coupled to beads was added. After incubation on ice for 30 min, unbound antibody was removed and the monolayers were washed
extensively with PBS and then fixed with methanol and stained with Giemsa stain. The field shown in panel A was selected to show one of
the few cells not covered with beads.
with the retrovirus alone. Thus, the expression of the
retrovirus env glycoprotein is not responsible for this result.
Influenza virus (HlNl or H7N7) also will not plaque on
tissue culture cells in the absence of trypsin, again because
the HA glycoprotein remains uncleaved (16). The uncleaved
HA protein does, however, have cell-binding activity (16).
Therefore, it was of interest to determine whether the fusion
protein expressed from the retrovirus would complement
influenza virus infection for plaque formation. It has been
shown that influenza virus which fuses at the cell surface
after acid treatment will not initiate infection (41). However,
it seemed possible that the presence of the cell surface
influenza virus HA protein with the fusion protein might
stimulate cell-to-cell fusion and the spread of the influenza
virus infection to adjacent cells, resulting in plaque forma-
tion. However, no plaques were observed on fusion protein-
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TABLE 1. Plaque formation
Virus titer (PFU/ml)' on:
Virus
(strain) Chick cells Chick cells pRFst-transfected
+ trypsin chick cells
NDV
AV 6.3 x 1010 6.3 x 1010 3.2 x 1010
B1 <1.0 x 101 6.0 x 1010 5.9 x 1010
W <1.0 x 101 8.0 x 1010 9.0 x 1010
Influenza
virus
HlNl <1.0 x 101 3.2 x 108 <1.0 x 101
H7N7 <1.0 x 101 1.3 x 107 <1.0 x 101
a Results of one experiment are shown. Identical results were obtained with
two different sets of transfected cells. Virus titers were determined four times
with each set of transfected cells.
expressing cells in the absence of trypsin (Table 1). This
result is not due to a failure of influenza virus to infect the
fusion protein-expressing cells. In a 2-h label with
[35S]methionine, influenza virus-infected pRFst cells and
pRCAS cells synthesized equivalent amounts of influenza
virus proteins (data not shown). Thus, influenza virus can
infect fusion protein-expressing cells but cannot spread to
adjacent cells.
Cell fusion. As noted above, cells expressing the cleaved
fusion protein at their cell surface showed no evidence of
cell-to-cell fusion (Fig. 4A). Indeed, scans of entire mono-
layers showed no cell with more than two nuclei. Fusion
assays are standardly done by mixing infected cells with
uninfected cells containing no viral proteins at their surfaces
(2). Therefore, fusion protein-expressing cells were mixed
with untransfected chick cells. No fusion was seen over the
entire monolayer (Fig. 4B). Since there have been reports
that the HN protein of paramyxoviruses is required for
fusion (5, 7, 21, 27, 28, 30, 32, 33), it was therefore of interest
to determine whether cells expressing the HN protein would
fuse with cells expressing the fusion protein. The expression
of the NDV HN protein in chick cells with the same
retrovirus vector has been previously described (22). Mix-
tures of fusion protein-expressing cells and cells expressing
the NDV HN protein are shown in Fig. 4C. No fusion was
observed. The monolayer appears slightly different from the
monolayers shown in Fig. 4A and B because the HN
protein-expressing cells are rounder than is typical of
chicken embryo fibroblasts (unpublished observations). The
cell mixtures shown in Fig. 4B and C were also incubated at
pH 5 and pH 8.5, and again no fusion was observed (data not
shown). In addition, treatment of pRFst-transfected cells or
untransfected cells with neuraminidase prior to the fusion
assay did not stimulate fusion (data not shown).
Fusion was, however, observed if the fusion protein-
expressing cells were infected with the avirulent NDV Bi
strain and mixed with uninfected cells (Fig. 5A). This fusion
was comparable or even more extensive than that seen after
virulent (AV) NDV infection of chick cells (Fig. 5B). As
expected, fusion was not observed when chick cells trans-
fected with pRCAS and infected with NDV strain Bi were
mixed with uninfected cells (Fig. SC). In addition, influenza
virus-infected fusion protein-expressing cells showed no
evidence of fusion when mixed with uninfected cells (data
not shown).
Since fusion protein-expressing cells would fuse only after
infection with NDV strain Bi, it was possible that the Bi
FIG. 4. Fusion assays with fusion protein-expressing cells. (A)
Confluent monolayer of cells expressing F1-F2. No uninfected cells
were added. (B) Cells expressing F1-F2 mixed with uninfected chick
cells as described in Materials and Methods. (C) Cells expressing
F1-F2 mixed with cells expressing the HN protein. In each case, the
entire monolayer was scanned for evidence of fusion. No cells
containing more than two nuclei were observed.
virus was providing an additional factor required for cell
fusion. Because of past reports of the requirement for HN
protein in cell fusion, it seemed likely that expression of the
HN protein was required. To test this idea, we transfected
fusion protein-expressing cells with the NDV HN gene
(pRHN DNA). After this transfection, numerous regions of
cell fusion were seen (for example, Fig. 6A). However,
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FIG. 5. Fusion assays with F1-F2-expressing cells infected with
NDV strain Bi. (A) Cells expressing F1-F2 and infected with NDV
strain Bl for 5 h were mixed with uninfected cells and incubated for
2 h. Most of the monolayer was involved in cell fusion. (B) Chick
cells (untransfected) infected with NDV strain AV for 5 h were
mixed with uninfected cells and incubated for 2 h. (C) Cells
transfected with pRCAS and infected with NDV strain B1 for 5 h
were mixed with uninfected cells and incubated for 2 h. No evidence
for cell fusion was seen over the entire monolayer.
transfection of fusion protein-expressing cells with the vec-
tor alone (pRCAS) did not result in any cell fusion (Fig. 6B).
Thus, the fusion protein-expressing cells are capable of
cell-to-cell fusion if the HN protein is expressed in the same
cell.
DISCUSSION
The coding region of the fusion protein gene derived from
a virulent strain of NDV, strain AV, was inserted into the
genome of an ALV derived from Rous sarcoma virus (11-
13). The fusion protein gene was placed in the position
occupied by the src gene and is presumably expressed as the
src gene in Rous sarcoma virus. Cells transfected with DNA
derived from this vector express a protein which is probably
the fusion protein since it is precipitated by antibody specific
for the fusion protein and it comigrates with the fusion
protein synthesized in NDV-infected cells.
Use of a retroviral vector allows the expression of a gene
in cells that will continue to grow and divide through
multiple passages. The vector used here was a replication-
competent virus (11). Therefore, transfected cells will re-
lease infectious virus which can then infect untransfected
cells, spreading the inserted gene throughout the culture.
Indeed, nearly all cells derived from the transfection of the
chick cells with the fusion protein gene-containing vector
expressed the fusion protein. Such a system allows one to
easily assess the properties of cells expressing the fusion
protein and the ability of these cells to support the growth of
avirulent NDV.
The fusion protein gene used here was derived from the
virulent NDV strain, AV. The fusion protein synthesized in
cells infected with this virus was proteolytically cleaved in
the trans-Golgi or trans-Golgi network and in the absence of
added trypsin (24). The protein expressed from the cDNA
derived from this gene was also proteolytically cleaved in the
absence of added trypsin. Furthermore, the expressed pro-
tein could be detected at the cell surface by monoclonal
antibody.
Cells expressing the fusion protein grew normally and
appeared identical to cells transfected with the retrovirus
alone. The fusion protein-expressing cells have been main-
tained through 30 passages, as have cells transfected with
pRantiFst and pRCAS. Even though the expressed fusion
protein was cleaved, no cell-to-cell fusion was observed at
any time after transfection. Nor was fusion observed when
untransfected chick cells were mixed with cells expressing
the fusion protein. However, cells expressing the fusion
protein could fuse if the cells were infected with an avirulent
strain of NDV. Avirulent strains of NDV have fusion pro-
teins that are not cleaved in tissue culture in the absence of
trypsin and are, therefore, unable to mediate fusion (25, 26).
Indeed, pRCAS-transfected cells infected with strain Bi did
not fuse; therefore, the fusion observed after infection of
pRFst-transfected cells with NDV strain Bi must be due to
the cleaved fusion protein expressed from the retrovirus
vector. Thus, fusion is only observed in cells expressing a
cleaved fusion protein and another viral protein contributed
by the NDV Bi infection. It has been reported that the
parainfluenza 3 virus fusion protein will not mediate fusion
unless the cells also express the HN protein (33). Some
earlier work also suggested a necessary role for the HN
protein (5, 7, 21, 27, 28, 32). Indeed, the NDV fusion
protein-expressing cells will fuse following transfection of
the HN protein gene, demonstrating that both the fusion
protein and the HN protein are required for membrane
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FIG. 6. Fusion assays with Fl-F2-expressing cells transfected with pRHN DNA. Cells expressing the fusion protein were transfected with
pRHN DNA (A) or pRCAS (B) by using lipofectin. Twenty-four hours after removal of the lipofectin-DNA mixture, monolayers were fixed
and stained with Giemsa stain as described in Materials and Methods. For each transfection, the entire monolayer was scanned for evidence
of cell-to-cell fusion. Following transfection with pRHN DNA, numerous regions of cell fusion containing from 5 to 30 nuclei were observed.
A typical region of fusion is shown in panel A. Following transfection with pRCAS DNA, no cells containing more than two nuclei were seen
over the entire monolayer. A typical field is shown in panel B. Similar results were obtained with three separate lines of fusion
protein-expressing cells derived from three separate transfections with pRFst DNA.
fusion in this system. Significantly, the HN protein must be
in the same cell as the cleaved fusion protein since mixtures
of cells expressing the HN protein and cells expressing the
fusion protein did not fuse.
The nature of the contribution of the HN protein in fusion
in this system is not clear. It has been previously suggested
that the HN protein serves to position the membranes in the
close proximity required for fusion (10). If so, other viral
attachment proteins should also function. Our results sug-
gest that other viral attachment glycoproteins expressed in
the same cell will not substitute for the HN protein. The
vector used to express the fusion protein was a replication-
competent ALV which expresses the env protein. Thus, cell
surfaces also contained the ALV glycoprotein. This protein
was unable to mediate cell-to-cell interactions required for
cell fusion. Nor could the influenza virus HA protein substi-
tute for the HN protein. Influenza virus HA protein ex-
pressed during infection of chick cells is not cleaved but is
active in cell binding (16). The HA protein present in
influenza virus-infected fusion protein-expressing cells
should therefore mediate binding to adjacent cells. How-
ever, no fusion was observed between uninfected cells and
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influenza virus-infected fusion protein-expressing cells.
These results argue for a specific role of the HN protein in
fusion beyond the cell attachment activity of the protein.
As described above, earlier work has resulted in con-
fficting conclusions about the requirements for membrane
fusion. The most direct test is the expression of the individ-
ual genes in cells. Again, conflicting results were obtained. It
has been reported that the expression of the simian virus 5
(29), the measles virus (1), or the respiratory syncytial virus
(31) fusion protein alone is sufficient to mediate cell-to-cell
fusion. In contrast, our results and those of Sakai and
Shibuta (33) argue for a necessary role of the HN protein.
The reasons for these different results are unclear except
that in each case different vectors and different cell types
were used to express the viral proteins. It is possible that a
requirement for the HN protein varies with the cell line used.
Another possible explanation for these conflicting results
is related to differences in the viruses. It is possible that
fusion requires two activities. For some viruses, such as
simian virus 5 and measles virus, the fusion protein may
carry both activities, while in other viruses such as NDV,
the fusion protein may carry one activity and the HN protein
may carry the other. Resolution of the problem will require
further characterization of different fusion proteins with the
same vectors and the same cells.
Cells expressing the fusion protein readily plaqued aviru-
lent NDV in the absence of trypsin. Further, the efficiency of
plating was equivalent to that observed in the presence of
trypsin. Thus, the expressed fusion protein can complement
the avirulent virus, providing a cleaved fusion protein re-
quired for plaque formation. This result underscores the
importance of the cleaved fusion protein in the cell-to-cell
spread of infection required for plaque formation.
In summary, we expressed the fusion protein gene derived
from a virulent NDV strain using a retroviral vector. The
expressed protein could complement infection by an aviru-
lent NDV strain, resulting in cell fusion and plaque forma-
tion in the absence of trypsin. Our results suggest that the
HN protein is required for fusion, that other viral attachment
proteins will not substitute, and that the HN protein must
reside in the same membrane as the fusion protein.
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